Suppression of Forkhead Box Protein O1 (FOXO1) Transcription Factor May Promote Adrenocortical Tumorigenesis
- 22 June 2017
- journal article
- research article
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 49 (08) , 631-637
Abstract
Despite recent comprehensive genetic analyses, molecular evidence for a pathophysiological continuum linking benign adrenocortical adenoma (ACA) and highly aggressive adrenocortical carcinoma (ACC) is still elusive. Using human tumor samples and the established ACC cell line SW-13, this study investigated potential regulatory roles for FOXO transcription factors, in modulating adrenocortical tumorigenesis. Adrenocortical tumor specimens (20 ACAs, 10 ACCs, and 9 normal adrenal tissue samples) obtained from 30 patients were analyzed for ubiquitously expressed FOXO transcription factors, FOXO1 and FOXO3 using qRT-PCR and immunohistochemistry. The SW-13 ACC cells were used to study the phenotypic effects of FOXO regulation in vitro. While FOXO3 expression remained unchanged in ACCs, FOXO1 expression was found to be significantly downregulated in 19/20 ACAs and 9/10 ACCs (p<0.0001 and p<0.05, respectively), suggesting a global role for FOXO1 suppression in promoting and maintaining adrenocortical dedifferentiation. Silencing of FOXO1 in SW-13 cells resulted in significant loss of viability (p<0.001) mediated by apoptosis as determined by quantitative Annexin V immunofluorescence analysis (p<0.01). FOXO1 silencing also augmented the migratory behavior of SW-13 cells (p<0.0001), suggesting distinct roles for FOXO1 in promoting viability and controlled motility of adrenocortical cells.Keywords
This publication has 23 references indexed in Scilit:
- Adrenocortical carcinoma (ACC): diagnosis, prognosis, and treatmentFrontiers in Cell and Developmental Biology, 2015
- The activating TERT promoter mutation C228T is recurrent in subsets of adrenal tumorsEndocrine-Related Cancer, 2014
- Recurrent activating mutation in PRKACA in cortisol-producing adrenal tumorsNature Genetics, 2014
- Constitutive Activation of PKA Catalytic Subunit in Adrenal Cushing's SyndromeNew England Journal of Medicine, 2014
- Adrenocortical CarcinomaEndocrine Reviews, 2013
- Adrenocortical Carcinoma: Current Therapeutic State-of-the-ArtJournal of Oncology, 2012
- Adrenocortical cancer: pathophysiology and clinical managementEndocrine-Related Cancer, 2007
- A genome-wide scan identifies mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in individuals with adrenocortical hyperplasiaNature Genetics, 2006
- The Clinically Inapparent Adrenal Mass: Update in Diagnosis and ManagementEndocrine Reviews, 2004
- Prevalence and natural history of adrenal incidentalomasEuropean Journal of Endocrinology, 2003